A federal judge in Baltimore issued a 10-day restraining order, blocking the shipment and sales of Fluticasone Propionate Nasal Spray (from Roxane Laboratories Inc.'s , FDA-approved last week) and Par Pharmaceutical Companies Inc.'s generic version of Flonase (GlaxoSmithKline), a nasal spray that treats allergic and nonallergic nasal symptoms.

GlaxoSmithKline obtained the restraining order one day after the company sued the FDA for allegedly ailed to follow its own regulations in approving the Flonase generic and failed to apply the same quality standards.

See full story from LA Times.